🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 3 study of the PI3Kδ inhibitor Zandelisib (ME-401) in combi...
Status
Terminated
Location
The Oncology Institute of Hope and Innovation
Start Date
2021-08-13
Trial ID
NCT04745832
Treatments Being Tested
This research study is being done to estimate the safety and efficacy of za...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-01
Trial ID
NCT05604417
Treatments Being Tested
This is the study of the PI3Kδ inhibitor Zandelisib (ME-401) in subjects wi...
Status
Terminated
Location
Oncology Institute of Hope and Innovation
Start Date
2019-06-25
Trial ID
NCT03768505
Treatments Being Tested
A Phase 2 study of Zandelisib with Venetoclax (VEN) and Rituximab (R) in su...
Status
Withdrawn
Location
Dana Farber Cancer Institute
Start Date
2022-11-22
Trial ID
NCT05209308
Treatments Being Tested